Crescent Biopharma Ownership | Who Owns Crescent Biopharma?
Crescent Biopharma Ownership Summary
Crescent Biopharma is owned by 0.55% institutional investors, 0.12% insiders, and 99.33% retail investors. Vanguard group is the largest institutional shareholder, holding 0.34% of CBIO shares.
CBIO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Crescent Biopharma | 0.55% | 0.12% | 99.33% |
| Sector | Healthcare Stocks | 232.20% | 10.74% | -142.94% |
| Industry | Biotech Stocks | 382.11% | 10.55% | -292.66% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 557.51K | 0.34% | $6.61M |
| Blackrock funding, inc. /de | 109.23K | 0.12% | $1.30M |
| Geode capital management | 91.08K | 0.10% | $1.08M |
| Jefferies financial group | 64.24K | 0.07% | $761.93K |
| Renaissance | 46.70K | 0.05% | $553.86K |
| Fmr | 1.41M | 0.04% | $16.82M |
| Fairmount funds management | 1.39M | 0.04% | $16.50M |
| Bvf inc/il | 1.39M | 0.04% | $16.50M |
| Vr adviser | 1.39M | 0.04% | $16.50M |
| Morgan stanley | 27.52K | 0.03% | $326.40K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Boxer capital management | 453.69K | 1.72% | $5.39M |
| Fairmount funds management | 1.39M | 1.48% | $16.50M |
| Vr adviser | 1.39M | 0.93% | $16.50M |
| Bvf inc/il | 1.39M | 0.67% | $16.50M |
| Logos global management lp | 600.00K | 0.64% | $7.13M |
| Tang capital management | 679.82K | 0.31% | $8.08M |
| Commodore capital lp | 450.83K | 0.26% | $5.36M |
| Perceptive advisors | 453.69K | 0.16% | $5.39M |
| Deep track capital, lp | 453.69K | 0.15% | $5.39M |
| Driehaus capital management | 302.46K | 0.03% | $3.60M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tang capital management | 679.82K | 0.31% | 629.67K |
| Price t rowe associates inc /md/ | 383.60K | 0.00% | 383.60K |
| Adage capital partners gp | 200.00K | 0.00% | 99.09K |
| Logos global management lp | 600.00K | 0.64% | 46.31K |
| Marshall wace, llp | 43.69K | 0.00% | 43.69K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Paradigm biocapital advisors lp | - | - | -642.72K |
| Frazier life sciences management | - | - | -272.95K |
| Braidwell lp | - | - | -261.50K |
| Soleus capital management | - | - | -200.00K |
| Wellington management group llp | 17.70K | - | -162.19K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Price t rowe associates inc /md/ | 383.60K | 0.00% | 383.60K | $4.56M |
| Marshall wace, llp | 43.69K | 0.00% | 43.69K | $519.52K |
| Two sigma investments, lp | 28.32K | 0.00% | 28.32K | $336.70K |
| Manufacturers life insurance company, the | 24.92K | 0.00% | 24.92K | $296.33K |
| Jane street group | 22.96K | - | 22.96K | $272.37K |
Sold Out
| Holder | Change |
|---|---|
| Raymond james financial | -50.00 |
| Barclays | -286.00 |
| Affinity asset advisors | -18.00K |
| Soleus capital management | -200.00K |
| Braidwell lp | -261.50K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 11 | -72.50% | 904,390 | -92.01% | - | 634.79% | 5 | -77.27% | 5 | -37.50% |
| Sep 30, 2025 | 7 | -75.86% | 837,114 | -92.21% | - | 27.94% | 5 | -82.76% | 1 | - |
| Jun 30, 2025 | 29 | - | 10,751,740 | - | 1,244 | - | 29 | - | - | - |
| Dec 31, 2024 | 1 | - | 15 | - | - | - | 1 | - | - | - |
| Dec 31, 2023 | 1 | -96.88% | 66 | -100.00% | - | 1.83% | 1 | -92.31% | - | -100.00% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 04, 2025 | Fairmount Funds Management LLC | Buy | $18.24M | |
| Dec 04, 2025 | Fairmount Funds Management LLC | Buy | $131.43 | |
| Aug 07, 2024 | Invus Public Equities, L.P. | - | Sell | $11.20K |
| Aug 08, 2024 | Invus Public Equities, L.P. | - | Sell | $50.01K |
| Aug 06, 2024 | Invus Public Equities, L.P. | - | Sell | $10.19K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | 2 | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
CBIO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools